Key statistics
On Tuesday, Pharming Group NV (PHGN:MUN) closed at 0.916, -14.87% below its 52-week high of 1.08, set on Jun 05, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.916 |
---|---|
High | 0.916 |
Low | 0.916 |
Bid | 0.88 |
Offer | 0.8915 |
Previous close | 0.94 |
Average volume | 8.73k |
---|---|
Shares outstanding | 680.31m |
Free float | 661.16m |
P/E (TTM) | -- |
Market cap | 615.89m EUR |
EPS (TTM) | -0.0183 EUR |
Data delayed at least 15 minutes, as of Jul 01 2025 07:13 BST.
More ▼
Announcements
- Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis
- Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders
- Pharming Group to participate in June investor conferences
- Pharming Group reports first quarter 2025 financial results and provides business update
- Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director
- Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
- Pharming Group to report first quarter 2025 financial results on May 8
- Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS
- Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
- Pharming Group announces the filing of its 2024 Annual Report and Form 20-F
More ▼